Use of real-time PCR as an alternative to conventional genotyping methods for the laboratory detection of lymphogranuloma venereum (LGV).


Journal

Diagnostic microbiology and infectious disease
ISSN: 1879-0070
Titre abrégé: Diagn Microbiol Infect Dis
Pays: United States
ID NLM: 8305899

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 21 06 2021
revised: 20 08 2021
accepted: 21 08 2021
pubmed: 28 9 2021
medline: 1 2 2022
entrez: 27 9 2021
Statut: ppublish

Résumé

Lymphogranuloma venereum (LGV) can be differentiated from non-LGV chlamydial infection using Sanger sequencing or molecular assays, including those that are commercially-available internationally. Here, we describe the performance of a rapid real-time PCR (RT-PCR)-based strategy in differentiating Chlamydia trachomatis infections associated with LGV or non-LGV serovars. One hundred three rectal swabs, previously genotyped using Sanger sequencing of the ompA gene as a reference method, were tested in the RT-PCR assays. All non-LGV specimens were correctly identified, but the RT-PCR failed to detect 1 LGV specimen, resulting in a sensitivity of 87.5% for the non-LGV/LGV RT-PCR assay. Additional performance characteristics (e.g., specificity, accuracy, and reproducibility) were all between 93% and 100% with a limit of detection ≤100 copies/reaction. Thus, this rapid RT-PCR method for LGV detection in clinical specimens is comparable to the reference method.

Identifiants

pubmed: 34571353
pii: S0732-8893(21)00224-8
doi: 10.1016/j.diagmicrobio.2021.115532
pmc: PMC8650105
mid: NIHMS1747714
pii:
doi:

Substances chimiques

Bacterial Outer Membrane Proteins 0
DNA, Bacterial 0
OMPA outer membrane proteins 149024-69-1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

115532

Subventions

Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States

Informations de copyright

Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors report no conflicts of interest relevant to this article.

Références

J Clin Microbiol. 1994 Feb;32(2):528-30
pubmed: 8150967
Emerg Infect Dis. 2014 Nov;20(11):1841-7
pubmed: 25340463
Sex Transm Infect. 2008 Aug;84(4):273-6
pubmed: 18283094
J Clin Microbiol. 2021 Jan 21;59(2):
pubmed: 33177120
Curr Infect Dis Rep. 2007 Mar;9(2):143-50
pubmed: 17324352
Clin Microbiol Infect. 2021 Jun;27(6):909.e1-909.e5
pubmed: 32771642
Emerg Infect Dis. 2009 Sep;15(9):1385-94
pubmed: 19788805
Sex Transm Dis. 2007 Jul;34(7):451-5
pubmed: 17075436
MMWR Recomm Rep. 2021 Jul 23;70(4):1-187
pubmed: 34292926
Sex Transm Infect. 2008 Aug;84(4):252-3
pubmed: 18647876
J Clin Microbiol. 2005 Oct;43(10):5412-3; author reply 5412-3
pubmed: 16208036
Microbiology (Reading). 2005 Mar;151(Pt 3):893-903
pubmed: 15758234
Emerg Infect Dis. 2005 Aug;11(8):1311-2
pubmed: 16110579
Sex Transm Dis. 2020 Mar;47(3):162-164
pubmed: 31876865
Clin Infect Dis. 2015 Dec 15;61 Suppl 8:S865-73
pubmed: 26602624
J Infect Dis. 2013 Sep;208(6):969-77
pubmed: 23776193
J Eur Acad Dermatol Venereol. 2019 Oct;33(10):1821-1828
pubmed: 31243838
Sex Transm Dis. 2017 Nov;44(11):691-694
pubmed: 28876314
Sex Transm Dis. 2021 Jun 1;:
pubmed: 34075001
Mol Cell Probes. 2006 Oct;20(5):290-7
pubmed: 16644182
PLoS One. 2021 Jul 8;16(7):e0254233
pubmed: 34237111
MMWR Morb Mortal Wkly Rep. 2016 Sep 02;65(34):920-1
pubmed: 27583686
PLoS One. 2020 Jun 4;15(6):e0233990
pubmed: 32497069
J Clin Microbiol. 2012 Nov;50(11):3548-55
pubmed: 22915612
Sci Rep. 2019 Dec 4;9(1):18327
pubmed: 31798000

Auteurs

Evonne N Woodson (EN)

Laboratory Leadership Service, Centers for Disease Control and Prevention, Atlanta, GA, USA; Division of STD Prevention, National Center for HIV, Hepatitis, STD, TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: phy2@cdc.gov.

Samantha S Katz (SS)

Division of STD Prevention, National Center for HIV, Hepatitis, STD, TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Sheree S Mosley (SS)

Division of STD Prevention, National Center for HIV, Hepatitis, STD, TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Damien C Danavall (DC)

Division of STD Prevention, National Center for HIV, Hepatitis, STD, TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Katherine E Bowden (KE)

Division of STD Prevention, National Center for HIV, Hepatitis, STD, TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Kai-Hua Chi (KH)

Division of STD Prevention, National Center for HIV, Hepatitis, STD, TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Brian H Raphael (BH)

Division of STD Prevention, National Center for HIV, Hepatitis, STD, TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH